Vertex Pharmaceuticals (VRTX) Exchange Rate Effect (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted quarterly Exchange Rate Effect of -$40.3 million for Q1 2026, down 232.13% year-over-year from $30.5 million in Q1 2025, and down 652.05% quarter-over-quarter from $7.3 million in Q4 2025.
Vertex Pharmaceuticals (VRTX) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals' Exchange Rate Effect history runs 18 years deep, the most recent figure standing at -$40.3 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 232.13% year-over-year to -$40.3 million; the TTM figure through Mar 2026 stood at $20.1 million (up 474.29% YoY), while the FY2025 annual figure was $90.9 million, up 313.38% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$40.3 million, down from $7.3 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $57.2 million in Q2 2025, with the low at -$47.3 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$2.5 million (2024), against an average of $335294.1.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect plunged 747.5% in 2022, then soared 2388.0% in 2025.
- Vertex Pharmaceuticals' Exchange Rate Effect stood at $40.8 million in 2022, then sank by 32.84% to $27.4 million in 2023, then plunged by 272.63% to -$47.3 million in 2024, then soared by 115.43% to $7.3 million in 2025, then plunged by 652.05% to -$40.3 million in 2026.
- Business Quant data shows VRTX's Exchange Rate Effect at -$40.3 million in Q1 2026, $7.3 million in Q4 2025, and -$4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 315,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.70 Mn |
| Jun 30, 2026 | -3.70 Mn |
| Mar 31, 2026 | -40.30 Mn |
| Mar 31, 2026 | -40.30 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Sep 30, 2025 | -4.10 Mn |
| Sep 30, 2025 | -4.10 Mn |
| Jun 30, 2025 | 57.20 Mn |
| Jun 30, 2025 | 57.20 Mn |
| Mar 31, 2025 | 30.50 Mn |
| Mar 31, 2025 | 30.50 Mn |
| Dec 31, 2024 | -47.30 Mn |
| Dec 31, 2024 | -47.30 Mn |
| Sep 30, 2024 | 22.80 Mn |
| Sep 30, 2024 | 22.80 Mn |
| Jun 30, 2024 | -2.50 Mn |
| Jun 30, 2024 | -2.50 Mn |
| Mar 31, 2024 | -15.60 Mn |
| Mar 31, 2024 | -15.60 Mn |